Transpact Enterprises
TRANSPACTENTERPRISESLTD NSE
Transpact Enterprises
HealthcareNSE: TRANSPACTENTERPRISESLTD BSE: TRANSPACT Medical Equipment
Key Fundamentals
MicrocapMedical EquipmentHealthcareMarket Cap
₹3.30 Cr
Volatility
Low Risk
P/E Ratio
38.6
EBITDA
₹0.12 Cr
Return on Equity
1.99%
Debt to Equity
0.11
Book Value
₹13.88
EPS
₹0
52W High
₹236.1
52W Low
₹81.47
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
1- Company has reduced debt.
Weaknesses
6- Stock is trading at 6.16 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding is low: 16.2%
- Company has a low return on equity of 0.70% over last 3 years.
- Company has high debtors of 203 days.
- Promoter holding has decreased over last 3 years: -16.5%
Growth Rate
Revenue Growth
80% higher than
3Y
Net Income Growth
800% higher than
3Y
Cash Flow Change
-203%
ROE
-110% lower than
3Y
ROCE
-104% higher than
3Y
EBITDA Margin (Avg.)
32.86%
Quarterly Results
| Particulars | Mar 2020 | Sep 2020 | Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.02 | 0 | 0.06 | 0 | 0.15 | 0 | 0 | 0 | 0 | 0 | 0.08 | 0.1 | 0.09 |
| Expenses | 0.04 | 0.06 | 0.02 | 0.23 | 0.14 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | 0.03 | 0.04 |
| Operating Profit | -0.02 | -0.06 | 0.04 | -0.23 | 0.01 | -0.03 | -0.03 | -0.03 | -0.03 | -0.03 | 0.06 | 0.07 | 0.05 |
| OPM % | -100% | — | 66.67% | — | 6.67% | — | — | — | — | — | 75% | 70% | 55.56% |
| Other Income | 0 | 0 | 0 | 0 | 0.01 | 0.05 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0 | 0 | 0 | 0.04 | 0.02 | 0.02 | 0.02 | 0.02 |
| PBT | -0.04 | -0.08 | 0.02 | -0.25 | 0 | 0.02 | -0.03 | -0.03 | -0.07 | -0.05 | 0.04 | 0.05 | 0.03 |
| Tax % | 0% | 0% | 50% | 0% | — | 0% | 0% | 0% | 0% | 0% | 0% | 0% | -33.33% |
| Net Profit | -0.05 | -0.08 | 0.01 | -0.25 | 0 | 0.02 | -0.03 | -0.03 | -0.06 | -0.05 | 0.05 | 0.05 | 0.04 |
| EPS in Rs | -1.29 | -2.07 | 0.26 | -6.46 | 0 | 0.52 | -0.78 | -0.78 | -1.55 | -1.29 | 1.29 | 1.29 | 1.03 |
Profit & Loss
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0.13 | 0 | 0.03 | 0.15 | 0.38 | 0 | 0.08 | 0.18 |
| Expenses | 0 | 0.07 | 0.05 | 0.09 | 0.16 | 0.34 | 0.08 | 0.36 | 0.41 | 0.06 | 0.04 | 0.06 |
| Operating Profit | 0 | -0.07 | -0.05 | -0.09 | -0.03 | -0.34 | -0.05 | -0.21 | -0.03 | -0.06 | 0.04 | 0.12 |
| OPM % | — | — | — | — | -23.08% | -1950% | -166.67% | -140% | -7.89% | — | 50% | 66.67% |
| Other Income | 0 | 0 | 0 | 0 | -0.23 | 0.02 | 0.03 | 0.03 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0.07 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0.02 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
| PBT | 0 | -0.07 | -0.05 | -0.09 | -0.28 | -0.43 | -0.06 | -0.22 | -0.07 | -0.1 | 0 | 0.08 |
| Tax % | — | 0% | 0% | 0% | 3.57% | 2.33% | 16.67% | 0% | 0% | 0% | — | -12.5% |
| Net Profit | 0 | -0.07 | -0.05 | -0.09 | -0.3 | -0.43 | -0.06 | -0.22 | -0.07 | -0.09 | 0.01 | 0.09 |
| EPS in Rs | 0 | -17.77 | -12.38 | -22.28 | -74.26 | -11.12 | -1.55 | -5.69 | -1.81 | -2.33 | 0.26 | 2.33 |
| Div. Payout % | — | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.01 | 0.04 | 0.04 | 0.04 | 0.04 | 0.39 | 0.39 | 0.39 | 0.39 | 0.39 | 0.39 | 0.39 |
| Reserves | 0.13 | 0.1 | 0.12 | 0.03 | -0.04 | 0.5 | 0.43 | 0.21 | 0.15 | 0.06 | 0.06 | 0.15 |
| Borrowings | 0.02 | 0.04 | 0.07 | 0.36 | 0.43 | 0.26 | 0.29 | 0.29 | 0.28 | 0.05 | 0.1 | 0.06 |
| Other Liabilities | -0.01 | 0.01 | 0 | 0.04 | 0.09 | 0.15 | 0.27 | 0.21 | 0.22 | 0.16 | 0.15 | 0.18 |
| Total Liabilities | 0.15 | 0.19 | 0.23 | 0.47 | 0.52 | 1.3 | 1.38 | 1.1 | 1.04 | 0.66 | 0.7 | 0.78 |
| Fixed Assets | 0.13 | 0.13 | 0.18 | 0.18 | 0.35 | 0.31 | 0.27 | 0.24 | 0.2 | 0.16 | 0.13 | 0.09 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 0.02 | 0.06 | 0.05 | 0.29 | 0.17 | 0.99 | 1.11 | 0.86 | 0.84 | 0.5 | 0.57 | 0.69 |
| Total Assets | 0.15 | 0.19 | 0.23 | 0.47 | 0.52 | 1.3 | 1.38 | 1.1 | 1.04 | 0.66 | 0.7 | 0.78 |
Cash Flow
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 0 | -0.12 | -0.05 | -0.24 | 0.07 | -1.14 | 0.01 | -0.87 | -0.01 | 0.39 | -0.4 | 0.05 |
| Investing | 0 | 0 | -0.05 | 0 | -0.19 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Financing | 0 | 0.12 | 0.1 | 0.29 | 0.08 | 1.14 | 0.03 | -0.29 | 0 | 0 | 0 | -0.04 |
| Net Cash Flow | 0 | 0 | 0 | 0.05 | -0.05 | 0 | 0.04 | -1.16 | -0.01 | 0.39 | -0.4 | 0.01 |
| Free Cash Flow | 0 | -0.12 | -0.1 | -0.24 | -0.12 | -1.14 | 0.01 | -0.87 | -0.01 | 0.39 | -0.4 | 0.05 |
| CFO/OP | — | 171 | 100 | 267 | -233 | 335 | -20 | 414 | 33 | -650 | -1,000 | 42 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | — | — | — | — | 84.23 | — | 0 | 0 | 0 | — | 456 | 203 |
| Inventory Days | — | — | — | — | 329 | — | — | 13.04 | 19.21 | — | — | 0 |
| Days Payable | — | — | — | — | 183 | — | — | 130 | 115 | — | — | — |
| Cash Conversion Cycle | — | — | — | — | 230 | — | 0 | -117 | -96.05 | — | 456 | 203 |
| Working Capital Days | — | — | — | — | -281 | — | -2,677 | -925 | -384 | — | 1,551 | 913 |
| ROCE % | 0% | -41.18% | -24.39% | -27.27% | -11.63% | -45.57% | -5.31% | -22% | -8.19% | -15.15% | 0% | 14.04% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Transpact Enterprises insights
57 extracted metrics + investor summaries across FY12–FY26.
Documents
1
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
15 Apr - Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended March 31, 2026. 15 Apr - Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended March 31, 2026.
2
Announcement under Regulation 30 (LODR)-Updates on Acquisition
9h - Subscribed Rs1.77 crore for 47,103 shares (5.80%) in Radiance MH Sunrise Eleven Pvt Ltd on March 9, 2026. 9h - Subscribed Rs1.77 crore for 47,103 shares (5.80%) in Radiance MH Sunrise Eleven Pvt Ltd on March 9, 2026.
3
Updates- Cancellation Of Schedule Of Analyst/ Institutional Investor Meeting.
17 Feb - Feb 18, 2026 Dolat Capital 1x1/group meeting (9:00am) cancelled, Mumbai. 17 Feb - Feb 18, 2026 Dolat Capital 1x1/group meeting (9:00am) cancelled, Mumbai.
4
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
16 Feb - Transcript of Analyst/ Investor Meet held on Tuesday, February 10,2025 16 Feb - Transcript of Analyst/ Investor Meet held on Tuesday, February 10,2025
5
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
12 Feb - Of Schedule of Analyst/ Institutional Investor meeting under SEBI (LODR), Regulation 2015 12 Feb - Of Schedule of Analyst/ Institutional Investor meeting under SEBI (LODR), Regulation 2015
1
Intimation Of Closure Of Register Of Members & Share Transfer Books For The 13Th Annual General Meeting (AGM) 10 Sept 2026
Intimation
4
Board Meeting Outcome for Outcome Of Board Meeting Held On 4Th September 2026 At 04:00 P.M. 4 Sept 2026
Outcome
Frequently Asked Questions about Transpact Enterprises
What does Transpact Enterprises Ltd do?
Incorporated in 2013, Transpact Enterprises
Ltd deals in investment portfolio, Investment advisory, Corporate funding, Market consulting, for various clients[1]
Where is Transpact Enterprises Ltd (542765) listed?
Transpact Enterprises Ltd trades as TRANSPACTENTERPRISESLTD on the NSE and under code TRANSPACT on the BSE.
Which sector does Transpact Enterprises Ltd belong to?
Transpact Enterprises Ltd is classified under the Healthcare sector, in the Medical Equipment industry.
What is the market capitalisation of Transpact Enterprises Ltd?
Transpact Enterprises Ltd has a market capitalisation of ₹3.3 Cr, which places it in the Small Cap band.
What is the PE ratio of Transpact Enterprises Ltd?
Transpact Enterprises Ltd trades at a PE ratio of 38.60, on earnings per share of ₹0, against a book value of ₹13.88 per share.
What is the 52-week high and low of Transpact Enterprises Ltd?
Over the last 52 weeks Transpact Enterprises Ltd has traded between ₹81.47 and ₹236.1.
What is the Return on Equity (ROE) of Transpact Enterprises Ltd?
Transpact Enterprises Ltd reported a return on equity of 1.99%. Its debt-to-equity ratio is 0.11.
Company Information
Incorporated in 2013, Transpact Enterprises Ltd deals in investment portfolio, Investment advisory, Corporate funding, Market consulting, for various clients[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/542765.md for Transpact Enterprises Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.